Sam Rubinsztain

ChronWell, Inc. is a digital health and therapeutics company based in Sunrise, FL. ChronWell offers a digital health platform called LiverHealthy™, which targets metabolic conditions like NAFLD and NASH. The platform provides healthcare providers and payors with a highly automated, scalable, and profitable solution to detect and manage NAFLD using clinical best-practices in partnership with the leading diagnostic and therapeutic leaders in the field. ChronWell aims to improve patients' lives beyond the walls of the physician's office and minimize the impact of chronic conditions on patients, providers, employers, and insurers. The private company partners with leading specialists to deploy new clinical service lines driven by digital innovation to manage large at-risk populations. The company was founded by Sam Rubinsztain and Salomon Sredni. Joe Rubinsztain has been the CEO of the company since 2017.